Where does Verinata Health, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Verinata Health, Inc. ranks #6,970 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Verinata Health, Inc. hold?

Verinata Health, Inc. holds 48 US utility patents granted between 2015 and 2025, spanning 10 technology areas.

What is Verinata Health, Inc.'s Innovation Score?

Verinata Health, Inc. has an Innovation Score of 43.8 out of 100 (top 27% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Verinata Health, Inc.'s patent grant rate increasing or decreasing?

Verinata Health, Inc.'s recent grant velocity is +9% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Verinata Health, Inc.'s patents?

Verinata Health, Inc.'s patents average 23.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Verinata Health, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Verinata Health, Inc.

Q: What technology areas does Verinata Health, Inc. focus on?

Verinata Health, Inc.'s top technology area is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes) with 45 patents, ranking #106 of 2,502 assignees active in that subclass. Grants appear in 10 CPC subclasses total.

USPTO PatentsView assignee record - 48 granted patents across 10 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Verinata ranks #6,970 of 49,997 tracked US assignees by granted-patent volume, with 48 patents across 10 technology areas.

#6,970
of 49,997 US assignees by volume: Top 27%
by Innovation Score (43.8/100): 23.5
avg claims per patent: +9%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R6970 · US Corporation #6,970 · 48 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-FLAT · BOOK-FULL

GRANTS-SMALL 48 grants
UPPER-Q #6,970/49,997
PHOTO-FINISH Ulthera
CPC-FOCUS C12Q · 10 areas
INNOV-PAR 43.8/100
CLAIMS-DENSE 23.5 claims/avg
TYPE-USCORP US Corporation
VEL-FLAT +9% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Ulthera, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Verinata’s 43.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 13.4 pts (31%) Velocity 5.1 pts (12%) Breadth 11.2 pts (26%) Claim depth 14.1 pts (32%)

Qualcomm Incorporated · highest

85
Altrix Medical · near

44
BIO Clean Environmen… · near

44
TRW Automotive and… · near

44
Universite Montpelli… · near

44
Verinata Health · this assignee

44
3D Lighting… · lowest

7

What this shows Verinata's Innovation Score is 43.8/100 (top 27% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Verinata?

Each dot is one of Verinata’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Verinata’s own 23.5 claims/patent is ABOVE the 15.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Verinata vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Verinata's grants concentrate

Verinata Health, Inc. is a focused PatentsView assignee: 10 CPC subclasses with 93.8% of grants classified under C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr). Peak complete grant year is 2016 (8 grants) versus a trough of 2 in 2015. By volume, Verinata sits between Universite D'angers and Vive Health LLC.

Verinata's three-year grant acceleration

Verinata Health, Inc. shows 13 grants in 2022–2024 against only 17 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Universite D'ange…

48
Ulthera

48
United Semiconduc…

48
Vapotherm

48
Victoria Link

48
Virent

48
Vitae Pharmaceuti…

48
Vive Health

48
Verinata Health ◀

48

What this shows Verinata holds 48 patents at rank #6,969, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Verinata

By rank, the assignees closest to #6,969 in granted patent volume.

Leaders in C12Q (Measuring OR Testing Processes Involving Enzymes)

Other assignees with the most granted patents in Verinata's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Verinata, neither rank-band nor same-CPC leaders (those blocks stay above). In C12Q (Measuring OR Testing Processes Involving Enzymes), Verinata ranks #106 of 2,502 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (44 here).

TRW Automotive Electronics and Components GmbH 44 BIO Clean Environmental Services, LLC 44 Universite Montpellier 2 Sciences ET Techniques 44 Altrix Medical, Inc. 44

Verinata's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

44 Top 27% higher than 73% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Verinata Health, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	2	4.2%
2016	8	16.7%
2017	2	4.2%
2018	4	8.3%
2019	6	12.5%
2020	8	16.7%
2021	3	6.3%
2022	6	12.5%
2023	3	6.3%
2024	4	8.3%
2025partial year	2	4.2%

Which technologies does Verinata Health, Inc. patent most?

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 45

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 33

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 13

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 10

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 5

Y10T - Technical Subjects Covered BY Former US Classification 5

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 3

G06F - Electric Digital Data Processing 2

G16C - Computational CHEMISTRY; CHEMOINFORMATICS; Computational Materials Science 2

G16Z - Information AND Communication Technology [ICT] Specially Adapted FOR Specific Application Fields, NOT Otherwise Provided FOR 2

Top 10 of 10 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Verinata Health, Inc.'s patent record in context - here's where to go next.

Verinata Health, Inc.'s lead technology class is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr), 93.8% of its portfolio - see every assignee active in that class. Explore C12Q
Ranked #6,970 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Verinata Health, Inc. against Universite D'angers, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 43.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.